HeartCare Medical Sets IPO Price at HK$171 Upper Limit, Oversubscribed by Nearly 191 Times

Neurointerventional medical device company HeartCare (06609.HK) will list on August 20. According to foreign media reports, HeartCare plans to price its shares at the upper end of the IPO price range at HK$171. At this price, the company will raise HK$1.13 billion. Broker data shows that HeartCare recorded a total of HK$21.67 billion in margin subscriptions. Based on the public offering target of nearly HK$113 million, the shares were oversubscribed by approximately 191 times.

Responsible Editor: Haiying Zhang